Cellular haemostaseology - Diagnosis and therapeutic monitoring of inherited and acquired functional platelet disorders

Transfusion Medicine and Hemotherapy

Volumn 34, Issue 1, 2007, Pages 4-5

  Klouche, M ^a  

^a LADR GmbH Medizinisches Versorgungszentrum   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; EDITORIAL; GENETIC DISORDER; HEMOSTASIS; HUMAN; PATIENT MONITORING; RISK FACTOR; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE DISORDER; THROMBOCYTE FUNCTION; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 33846642092     PISSN: 16603796     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098193     Document Type: Editorial

References (5)

1. Jurk K, Kehrel BE: Inherited and acquired disorders of platelet function. Transfus Med Hemother 2007;DOI 10.1159/000098178.
2. Klouche M: Diagnostic Methods for Platelet Function Analysis. Transfusion Med Hemother 2007 DOI: 10.1159/000098179
3. Lösche W, Heptinstall S: Value of platelet activation markers as prothrombotic risk indicators. Transfus Med Hemother 2007;DOI: 10.1159/000097497
4. Ahrens I, Schwarz M, Peter K, Bode C: Therapeutic inhibitors of platelet aggregation - from aspirin to integrin blockers. Transfusion Med Hemother 2007;DOI 10.1159/000097664.
5. Streif W, Olivieri M, Weickardt St, Eberl W, Knoefler R, for the members of the Thromkid study group of the GTH: Thromkid - a competence network for functional platelet abnormalities. Transfusion Med Hemother 2007;DOI 10.1159/000097848.